文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

术前内科会诊与术后不良结局减少及医疗流程使用的关系:加拿大安大略省居民研究

Association of Preoperative Medical Consultation With Reduction in Adverse Postoperative Outcomes and Use of Processes of Care Among Residents of Ontario, Canada.
PubMed 文献 · JAMA Intern Med · 2023-01-01
一句话结论在安大略省接受中高危非心脏手术的40岁及以上居民中,术前4个月内接受内科会诊与术后30天死亡率等不良结局风险升高相关(OR 1.19),而非降低。

该回顾性队列研究利用安大略省关联行政数据库,纳入2005年4月1日至2018年3月31日出院、年龄40岁及以上、首次接受符合条件的中高危非心脏手术的居民,共530 473例(平均[SD]年龄67.1[10.6]岁;女性278 903例[52.6%]),其中186 299例(35.1%)在术前4个月内接受内科会诊。倾向性评分匹配后得到179 809对匹配良好的患者(占全队列67.8%)。会诊组30天死亡率0.9%(n=1534) vs 对照组0.7%(n=1299),OR 1.19(95%CI 1.11-1.29);1年死亡率OR 1.15(95%CI 1.11-1.19)、住院卒中OR 1.21(95%CI 1.06-1.37)、住院机械通气OR 1.38(95%CI 1.31-1.45)、30天急诊就诊OR 1.07(95%CI 1.05-1.09)在会诊组均更高,住院心肌梗死率无差异。会诊组急性期住院时间平均(SD)6.0(9.3)天 vs 对照组5.6(10.0)天(差值0.4[95%CI 0.3-0.5]天),30天总医疗系统费用中位数(IQR)会诊组高317加元(229-959加元)(235美元[170-711美元])。术前内科会诊与术前超声心动图(OR 2.64;95%CI 2.59-2.69)、心脏负荷试验(OR 2.50;95%CI 2.43-2.56)使用增加及新

要点

  • 在530 473例40岁及以上首次中高危非心脏手术患者中,35.1%接受术前4个月内内科会诊,匹配后30天死亡率会诊组0.9%(n=1534) vs 对照组0.7%(n=1299),OR 1.19(95%CI 1.11-1.29)。
  • 会诊组1年死亡率OR 1.15(95%CI 1.11-1.19)、住院卒中OR 1.21(95%CI 1.06-1.37)、住院机械通气OR 1.38(95%CI 1.31-1.45)、30天急诊就诊OR 1.07(95%CI 1.05-1.09)均更高,住院心肌梗死率无差异。
  • 会诊组急性期住院时间平均6.0天 vs 5.6天(差值0.4天[95%CI 0.3-0.5]),30天总医疗系统费用中位数高317加元(229-959加元)。
  • 术前内科会诊与术前超声心动图(OR 2.64;95%CI 2.59-2.69)、心脏负荷试验(OR 2.50;95%CI 2.43-2.56)使用增加及新处方β受体阻滞剂几率更高(OR 2.96;95%CI 2.82-3.12)相关。
  • 作者认为,术前内科会诊未与术后不良结局减少相关,反而与增加相关,提示需进一步细化目标人群、流程和干预,并建议转诊及后续检查应基于个体化风险获益考虑。

适用人群与场景

  • 安大略省居民,年龄40岁及以上,首次接受符合条件的中高危非心脏手术,出院日期在2005年4月1日至2018年3月31日之间。
  • 暴露为术前4个月内接受内科会诊;使用倾向性评分匹配调整会诊与未会诊患者的差异。

研究设计与关键结果

  • 研究类型:回顾性队列研究,使用安大略省关联行政数据库,纳入530 473例(平均[SD]年龄67.1[10.6]岁;女性278 903例[52.6%]),其中186 299例(35.1%)接受术前内科会诊;倾向性评分匹配后得到179 809对匹配良好的患者(占全队列67.8%)。
  • 主要终点:30天全因术后死亡率会诊组0.9%(n=1534) vs 对照组0.7%(n=1299),OR 1.19(95%CI 1.11-1.29)。
  • 关键次要终点:1年死亡率OR 1.15(95%CI 1.11-1.19);住院卒中OR 1.21(95%CI 1.06-1.37);住院机械通气OR 1.38(95%CI 1.31-1.45);30天急诊就诊OR 1.07(95%CI 1.05-1.09);住院心肌梗死率无差异。
  • 住院时间:会诊组平均(SD)6.0(9.3)天 vs 对照组5.6(10.0)天,差值0.4天(95%CI 0.3-0.5)。
  • 费用:30天总医疗系统费用中位数(IQR)会诊组高317加元(229-959加元)(235美元[170-711美元])。
  • 医疗流程:术前内科会诊与术前超声心动图使用增加(OR 2.64;95%CI 2.59-2.69)、心脏负荷试验使用增加(OR 2.50;95%CI 2.43-2.56)及新处方β受体阻滞剂几率更高(OR 2.96;95%CI 2.82-3.12)相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(使用关联行政数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,术前内科会诊未与术后不良结局减少相关,反而与增加相关,提示需进一步细化目标人群、流程和干预。
  • 作者建议,转诊术前内科会诊及后续检查应基于个体化风险获益考虑。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: It is uncertain whether preoperative medical consultation reduces adverse postoperative clinical outcomes.

OBJECTIVE: To investigate the association of preoperative medical consultation with reduction in adverse postoperative outcomes and use of processes of care.

DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study using linked administrative databases from an independent research institute housing routinely collected health data for Ontario's 14 million residents, including sociodemographic features, physician characteristics and services, and receipt of inpatient and outpatient care. The study sample included Ontario residents aged 40 years or older who underwent their first qualifying intermediate- to high-risk noncardiac operation. Propensity score matching was used to adjust for differences between patients who did and did not undergo preoperative medical consultation with discharge dates between April 1, 2005, and March 31, 2018. The data were analyzed from December 20, 2021, to May 15, 2022.

EXPOSURES: Receipt of preoperative medical consultation in the 4 months preceding the index surgery.

MAIN OUTCOMES AND MEASURES: The primary outcome was 30-day all-cause postoperative mortality. Secondary outcomes included 1-year mortality, inpatient myocardial infarction and stroke, in-hospital mechanical ventilation, length of stay, and 30-day health system costs.

RESULTS: Of the total 530 473 individuals (mean [SD] age, 67.1 [10.6] years; 278 903 [52.6%] female) included in the study, 186 299 (35.1%) received preoperative medical consultation. Propensity score matching resulted in 179 809 well-matched pairs (67.8% of the full cohort). The 30-day mortality rate was 0.9% (n = 1534) in the consultation group and 0.7% (n = 1299) in the control group (odds ratio [OR], 1.19; 95% CI, 1.11-1.29). The ORs for 1 year mortality (OR, 1.15; 95% CI, 1.11-1.19), inpatient stroke (OR, 1.21; 95% CI, 1.06-1.37), in-hospital mechanical ventilation (OR, 1.38; 95% CI, 1.31-1.45), and 30-day emergency department visits (OR, 1.07; 95% CI, 1.05-1.09) were higher in the consultation group; however, the rates of inpatient myocardial infarction did not differ. The lengths of stay in acute care were a mean (SD) 6.0 (9.3) days in the consultation group and 5.6 (10.0) days in the control group (difference, 0.4 [95% CI, 0.3-0.5] days), and the median (IQR) total 30-day health system cost was CAD $317 ($229-$959) (US $235 [$170-$711]) higher in the consultation group. Preoperative medical consultation was associated with increased use of preoperative echocardiography (OR, 2.64; 95% CI, 2.59-2.69) and cardiac stress tests (OR, 2.50; 95% CI, 2.43-2.56) and higher odds of receiving a new prescription for β-blockers (OR, 2.96; 95% CI, 2.82-3.12).

CONCLUSIONS AND RELEVANCE: In this cohort study, preoperative medical consultation was not associated with a reduction but rather with an increase in adverse postoperative outcomes, suggesting a need for further refinement of target populations, processes, and interventions related to preoperative medical consultation. These findings highlight the need for further research and suggest that referral for preoperative medical consultation and subsequent testing should be carefully guided by individual-level consideration of risks and benefits.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Beckerleg W, Kobewka D, Wijeysundera DN, et al. Association of Preoperative Medical Consultation With Reduction in Adverse Postoperative Outcomes and Use of Processes of Care Among Residents of Ontario, Canada. JAMA Intern Med. 2023. PMID: 36972037. doi:10.1001/jamainternmed.2023.0325

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。